{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:48:07Z","timestamp":1787496487475,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062502"],"award-info":[{"award-number":["R01AG062502"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG028716"],"award-info":[{"award-number":["P30AG028716"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92023D00002"],"award-info":[{"award-number":["75N92023D00002"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92023D00005"],"award-info":[{"award-number":["75N92023D00005"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92023D00004"],"award-info":[{"award-number":["75N92023D00004"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92023D00006"],"award-info":[{"award-number":["75N92023D00006"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92023D00003"],"award-info":[{"award-number":["75N92023D00003"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11606-025-09692-3","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:52:25Z","timestamp":1751892745000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Polypharmacy and Physical Function in Middle-aged Adults: Findings from the CARDIA Function Study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-3846","authenticated-orcid":false,"given":"Caroline E.","family":"Sloan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa C.","family":"Ashner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara L.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett T.","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankeet S.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley Pettee","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Barrett","family":"Bowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"1","key":"9692_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s41256-023-00311-4","volume":"8","author":"X Wang","year":"2023","unstructured":"Wang X, Liu K, Shirai K, et al. Prevalence and trends of polypharmacy in U.S. adults, 1999-2018. Glob Health Res Policy. Jul 12 2023;8(1):25. https:\/\/doi.org\/10.1186\/s41256-023-00311-4","journal-title":"Glob Health Res Policy"},{"issue":"8","key":"9692_CR2","doi-asserted-by":"publisher","first-page":"e0255642","DOI":"10.1371\/journal.pone.0255642","volume":"16","author":"EH Young","year":"2021","unstructured":"Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. https:\/\/doi.org\/10.1371\/journal.pone.0255642","journal-title":"PLoS One."},{"issue":"2","key":"9692_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc. Feb 2020;21(2):181-187. https:\/\/doi.org\/10.1016\/j.jamda.2019.10.022","journal-title":"J Am Med Dir Assoc."},{"issue":"12","key":"9692_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14740338.2018.1546841","volume":"17","author":"JW Wastesson","year":"2018","unstructured":"Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. Dec 2018;17(12):1185-1196. https:\/\/doi.org\/10.1080\/14740338.2018.1546841","journal-title":"Expert Opin Drug Saf."},{"issue":"9","key":"9692_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s11606-019-05106-3","volume":"34","author":"A Katsimpris","year":"2019","unstructured":"Katsimpris A, Linseisen J, Meisinger C, Volaklis K. The Association Between Polypharmacy and Physical Function in Older Adults: a Systematic Review. J Gen Intern Med. Sep 2019;34(9):1865-1873. https:\/\/doi.org\/10.1007\/s11606-019-05106-3","journal-title":"J Gen Intern Med."},{"issue":"7","key":"9692_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2023","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2023 updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. Jul 2023;71(7):2052-2081. https:\/\/doi.org\/10.1111\/jgs.18372","journal-title":"J Am Geriatr Soc"},{"key":"9692_CR7","doi-asserted-by":"publisher","unstructured":"Fernandez A, Gomez F, Curcio CL, Pineda E, Fernandes de Souza J. Prevalence and impact of potentially inappropriate medication on community-dwelling older adults. Biomedica. Mar 19 2021;41(1):111\u2013122. Prevalencia e impacto de la medicacion potencialmente inapropiada en ancianos que viven en comunidad. https:\/\/doi.org\/10.7705\/biomedica.5787","DOI":"10.7705\/biomedica.5787"},{"issue":"3","key":"9692_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11096-020-01165-3","volume":"43","author":"E Kose","year":"2021","unstructured":"Kose E, Hirai T, Seki T, Yasuno N. The impact of decreasing potentially inappropriate medications on activities of daily living in a convalescent rehabilitation setting. Int J Clin Pharm. Jun 2021;43(3):577-585. https:\/\/doi.org\/10.1007\/s11096-020-01165-3","journal-title":"Int J Clin Pharm."},{"issue":"10","key":"9692_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s12603-022-1847-z","volume":"26","author":"LC Meng","year":"2022","unstructured":"Meng LC, Hsiao FY, Huang ST, Lu WH, Peng LN, Chen LK. Intrinsic Capacity Impairment Patterns and their Associations with Unfavorable Medication Utilization: A Nationwide Population-Based Study of 37,993 Community-Dwelling Older Adults. J Nutr Health Aging. 2022;26(10):918-925. https:\/\/doi.org\/10.1007\/s12603-022-1847-z","journal-title":"J Nutr Health Aging."},{"issue":"7","key":"9692_CR10","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1111\/bcp.14685","volume":"87","author":"MP Oktora","year":"2021","unstructured":"Oktora MP, Alfian SD, Bos HJ, et al. Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle-aged people treated for diabetes. Br J Clin Pharmacol. Jul 2021;87(7):2807-2817. https:\/\/doi.org\/10.1111\/bcp.14685","journal-title":"Br J Clin Pharmacol."},{"issue":"2","key":"9692_CR11","first-page":"893","volume":"112","author":"T Tatum","year":"2019","unstructured":"Tatum T, Curry P, Dunne B, Walsh K, Bennett K. Polypharmacy Rates among Patients over 45 years. Ir Med J. Mar 14 2019;112(2):893.","journal-title":"Ir Med J."},{"issue":"3","key":"9692_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.14336\/AD.2022.1107","volume":"14","author":"A Salih","year":"2023","unstructured":"Salih A, Nichols T, Szabo L, Petersen SE, Raisi-Estabragh Z. Conceptual Overview of Biological Age Estimation. Aging Dis. Jun 1 2023;14(3):583-588. https:\/\/doi.org\/10.14336\/AD.2022.1107","journal-title":"Aging Dis."},{"issue":"7","key":"9692_CR13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ggi.12359","volume":"15","author":"MH Chiu","year":"2015","unstructured":"Chiu MH, Lee HD, Hwang HF, Wang SC, Lin MR. Medication use and fall-risk assessment for falls in an acute care hospital. Geriatr Gerontol Int. Jul 2015;15(7):856-63. https:\/\/doi.org\/10.1111\/ggi.12359","journal-title":"Geriatr Gerontol Int."},{"issue":"1","key":"9692_CR14","doi-asserted-by":"publisher","first-page":"e018404","DOI":"10.1136\/bmjopen-2017-018404","volume":"8","author":"P Hanlon","year":"2018","unstructured":"Hanlon P, Nicholl BI, Jani BD, et al. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open. Jan 14 2018;8(1):e018404. https:\/\/doi.org\/10.1136\/bmjopen-2017-018404","journal-title":"BMJ Open."},{"issue":"6","key":"9692_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00125-021-05394-7","volume":"64","author":"A Hohn","year":"2021","unstructured":"Hohn A, Jeyam A, Caparrotta TM, et al. The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes. Diabetologia. Jun 2021;64(6):1309-1319. https:\/\/doi.org\/10.1007\/s00125-021-05394-7","journal-title":"Diabetologia."},{"issue":"6","key":"9692_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1159\/000516532","volume":"145","author":"H Kimura","year":"2021","unstructured":"Kimura H, Kalantar-Zadeh K, Rhee CM, Streja E, Sy J. Polypharmacy and Frailty among Hemodialysis Patients. Nephron. 2021;145(6):624-632. https:\/\/doi.org\/10.1159\/000516532","journal-title":"Nephron."},{"key":"9692_CR17","doi-asserted-by":"publisher","first-page":"204209862092985","DOI":"10.1177\/2042098620929852","volume":"11","author":"SR Neal","year":"2020","unstructured":"Neal SR, Wood AD, Ablett AD, et al. Anticholinergic burden in middle-aged women and recurrent falls in later life: findings from the Aberdeen prospective osteoporosis screening study (APOSS). Ther Adv Drug Saf. 2020;11:2042098620929852. https:\/\/doi.org\/10.1177\/2042098620929852","journal-title":"Ther Adv Drug Saf."},{"issue":"Supplement_1","key":"9692_CR18","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","volume":"48","author":"American Diabetes Association Professional Practice C","year":"2025","unstructured":"American Diabetes Association Professional Practice C. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025. Diabetes Care. Jan 1 2025;48(Supplement_1):S181-S206. https:\/\/doi.org\/10.2337\/dc25-S009","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"9692_CR19","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.2337\/dc25-S010","volume":"48","author":"American Diabetes Association Professional Practice C","year":"2025","unstructured":"American Diabetes Association Professional Practice C. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025. Diabetes Care. Jan 1 2025;48(Supplement_1):S207-S238. https:\/\/doi.org\/10.2337\/dc25-S010","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"9692_CR20","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.2337\/dc25-S011","volume":"48","author":"American Diabetes Association Professional Practice C","year":"2025","unstructured":"American Diabetes Association Professional Practice C. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025. Diabetes Care. Jan 1 2025;48(Supplement_1):S239-S251. https:\/\/doi.org\/10.2337\/dc25-S011","journal-title":"Diabetes Care"},{"issue":"17","key":"9692_CR21","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. May 3 2022;79(17):e263-e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"9692_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0165025414533223","volume":"39","author":"ME Lachman","year":"2015","unstructured":"Lachman ME, Teshale S, Agrigoroaei S. Midlife as a pivotal period in the life course: Balancing growth and decline at the crossroads of youth and old age. Int J Behav Dev. Jan 2015;39(1):20-31. https:\/\/doi.org\/10.1177\/0165025414533223","journal-title":"Int J Behav Dev."},{"issue":"8","key":"9692_CR23","doi-asserted-by":"publisher","first-page":"e069149","DOI":"10.1136\/bmjopen-2022-069149","volume":"13","author":"DH Solomon","year":"2023","unstructured":"Solomon DH, Santacroce L, Shadyab A, et al. Derivation and external validation of a risk score for clinically important declines in health and function among two longitudinal cohorts of women in the mid-life. BMJ Open. Aug 9 2023;13(8):e069149. https:\/\/doi.org\/10.1136\/bmjopen-2022-069149","journal-title":"BMJ Open."},{"issue":"11","key":"9692_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","volume":"41","author":"GD Friedman","year":"1988","unstructured":"Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105-16. https:\/\/doi.org\/10.1016\/0895-4356(88)90080-7","journal-title":"J Clin Epidemiol."},{"key":"9692_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.conctc.2017.12.003","volume":"9","author":"E Funkhouser","year":"2018","unstructured":"Funkhouser E, Wammack J, Roche C, Reis J, Sidney S, Schreiner P. Where are they now? Retention strategies over 25 years in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Contemp Clin Trials Commun. Mar 2018;9:64-70. https:\/\/doi.org\/10.1016\/j.conctc.2017.12.003","journal-title":"Contemp Clin Trials Commun."},{"issue":"3","key":"9692_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jacc.2021.05.022","volume":"78","author":"DM Lloyd-Jones","year":"2021","unstructured":"Lloyd-Jones DM, Lewis CE, Schreiner PJ, Shikany JM, Sidney S, Reis JP. The Coronary Artery Risk Development In Young Adults (CARDIA) Study: JACC Focus Seminar 8\/8. J Am Coll Cardiol. Jul 20 2021;78(3):260-277. https:\/\/doi.org\/10.1016\/j.jacc.2021.05.022","journal-title":"J Am Coll Cardiol."},{"key":"9692_CR27","doi-asserted-by":"publisher","unstructured":"Burrows BT, Sloane R, Faldowski R, et al. Development of a physical performance summary score in middle age: Findings from the CARDIA Function study. Am J Epidemiol. Dec 23 2024;https:\/\/doi.org\/10.1093\/aje\/kwae463","DOI":"10.1093\/aje\/kwae463"},{"issue":"1","key":"9692_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. Oct 10 2017;17(1):230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr."},{"key":"9692_CR29","unstructured":"CARDIA. Year 35 (2020\u20132022) Manual of Operations Phase 2: Chapter 13 - CARDIA Function Study. Accessed 11\/21\/2024, www.cardia.dopm.uab.edu\/images\/more\/pdf\/MooY35\/Phase2\/chapter13.pdf"},{"issue":"8","key":"9692_CR30","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1249\/MSS.0000000000000278","volume":"46","author":"KP Gabriel","year":"2014","unstructured":"Gabriel KP, Sidney S, Jacobs DR, Jr., et al. Convergent validity of a brief self-reported physical activity questionnaire. Med Sci Sports Exerc. Aug 2014;46(8):1570-7. https:\/\/doi.org\/10.1249\/MSS.0000000000000278","journal-title":"Med Sci Sports Exerc."},{"issue":"19","key":"9692_CR31","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2018.14854","volume":"320","author":"KL Piercy","year":"2018","unstructured":"Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA. Nov 20 2018;320(19):2020-2028. https:\/\/doi.org\/10.1001\/jama.2018.14854","journal-title":"JAMA."},{"issue":"5","key":"9692_CR32","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","volume":"146","author":"DM Lloyd-Jones","year":"2022","unstructured":"Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Circulation. Aug 2 2022;146(5):e18-e43. https:\/\/doi.org\/10.1161\/CIR.0000000000001078","journal-title":"Circulation."},{"key":"9692_CR33","doi-asserted-by":"publisher","first-page":"263355652412422","DOI":"10.1177\/26335565241242277","volume":"14","author":"CB Bowling","year":"2024","unstructured":"Bowling CB, Faldowski RA, Sloane R, et al. Multimorbidity trajectories in early adulthood and middle age: Findings from the CARDIA prospective cohort study. J Multimorb Comorb. Jan-Dec 2024;14:26335565241242277. https:\/\/doi.org\/10.1177\/26335565241242277","journal-title":"J Multimorb Comorb. Jan-Dec"},{"issue":"34","key":"9692_CR34","doi-asserted-by":"publisher","first-page":"e27073","DOI":"10.1097\/MD.0000000000027073","volume":"100","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Itoh T, Yabe A, et al. Polypharmacy is associated with malnutrition and activities of daily living disability among daycare facility users: A cross-sectional study. Medicine (Baltimore). Aug 27 2021;100(34):e27073. https:\/\/doi.org\/10.1097\/MD.0000000000027073","journal-title":"Medicine (Baltimore)."},{"key":"9692_CR35","doi-asserted-by":"publisher","unstructured":"Portela D, Almada M, Midao L, Costa E. Instrumental Activities of Daily Living (iADL) Limitations in Europe: An Assessment of SHARE Data. Int J Environ Res Public Health. Oct 10 2020;17(20)https:\/\/doi.org\/10.3390\/ijerph17207387","DOI":"10.3390\/ijerph17207387"},{"issue":"10","key":"9692_CR36","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/pds.5506","volume":"31","author":"J Guillot","year":"2022","unstructured":"Guillot J, Rentsch CT, Gordon KS, Justice AC, Bezin J. Potentially inappropriate medication use by level of polypharmacy among US Veterans 49-64 and 65-70 years old. Pharmacoepidemiol Drug Saf. Oct 2022;31(10):1056-1074. https:\/\/doi.org\/10.1002\/pds.5506","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"1","key":"9692_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/gerona\/glx074","volume":"73","author":"M Konig","year":"2017","unstructured":"Konig M, Spira D, Demuth I, Steinhagen-Thiessen E, Norman K. Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. Dec 12 2017;73(1):117-122. https:\/\/doi.org\/10.1093\/gerona\/glx074","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"7","key":"9692_CR38","doi-asserted-by":"publisher","first-page":"e0287263","DOI":"10.1371\/journal.pone.0287263","volume":"18","author":"J Niebuur","year":"2023","unstructured":"Niebuur J, Vonk JM, Du Y, et al. Lifestyle factors related to prevalent chronic disease multimorbidity: A population-based cross-sectional study. PLoS One. 2023;18(7):e0287263. https:\/\/doi.org\/10.1371\/journal.pone.0287263","journal-title":"PLoS One."},{"issue":"9","key":"9692_CR39","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/jgs.16501","volume":"68","author":"N Thanoo","year":"2020","unstructured":"Thanoo N, Gilbert AL, Trainor S, et al. The Relationship between Polypharmacy and Physical Activity in Those with or at Risk of Knee Osteoarthritis. J Am Geriatr Soc. Sep 2020;68(9):2015-2020. https:\/\/doi.org\/10.1111\/jgs.16501","journal-title":"J Am Geriatr Soc."},{"issue":"6","key":"9692_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25318\/82-003-x202200600001-eng","volume":"33","author":"DA Harris","year":"2022","unstructured":"Harris DA, Guo Y, Nakhla N, et al. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians. Health Rep. Jun 15 2022;33(6):3-16. https:\/\/doi.org\/10.25318\/82-003-x202200600001-eng","journal-title":"Health Rep."},{"issue":"1","key":"9692_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/ageing\/afu141","volume":"44","author":"K Richardson","year":"2015","unstructured":"Richardson K, Bennett K, Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing. Jan 2015;44(1):90-6. https:\/\/doi.org\/10.1093\/ageing\/afu141","journal-title":"Age Ageing."},{"issue":"12","key":"9692_CR42","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1111\/jgs.16773","volume":"68","author":"JA Womack","year":"2020","unstructured":"Womack JA, Murphy TE, Bathulapalli H, et al. Serious Falls in Middle-Aged Veterans: Development and Validation of a Predictive Risk Model. J Am Geriatr Soc. Dec 2020;68(12):2847-2854. https:\/\/doi.org\/10.1111\/jgs.16773","journal-title":"J Am Geriatr Soc."},{"issue":"9","key":"9692_CR43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40263-018-0542-4","volume":"32","author":"N Bareis","year":"2018","unstructured":"Bareis N, Sando TA, Mezuk B, Cohen SA. Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey. CNS Drugs. Sep 2018;32(9):863-871. https:\/\/doi.org\/10.1007\/s40263-018-0542-4","journal-title":"CNS Drugs."},{"key":"9692_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12913-014-0484-6","volume":"14","author":"JA Cooper","year":"2014","unstructured":"Cooper JA, Ryan C, Smith SM, et al. The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria. BMC Health Serv Res. Oct 30 2014;14:484. https:\/\/doi.org\/10.1186\/s12913-014-0484-6","journal-title":"BMC Health Serv Res."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09692-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:05:55Z","timestamp":1783382755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["9692"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09692-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work has not been previously presented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior Presentations"}},{"value":"Drs. Sloan, Gabriel, and Bowling report grants from the National Institute on Aging during the conduct of the study. Dr. Sloan is a Health and Aging Policy Fellow and American Political Science Association Fellow and is supported by the John A. Hartford Foundation. Dr. McDermott reports grants from the National Heart, Lung, and Blood Institute during the conduct of the study, as well as personal fees from Academy of Managed Care Pharmacy Research Institute\/Biologics and Biosimilars Collective Intelligence Consortium outside the submitted work. The other authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This analysis was approved by the Duke University Institutional Review Board (IRB; Pro00103278) and the University of Alabama at Birmingham IRB, which serves as the single-IRB for the CARDIA study (IRB-300004988\u2013046). Consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}